e-Article
Re: CRISPR/Cas9-Mediated Glycolate Oxidase Disruption is an Efficacious and Safe Treatment for Primary Hyperoxaluria Type i
Document Type
Note
Author
Source
In: Journal of Urology . (Journal of Urology, 2019, 201(5):853-854)
Subject
Language
English
ISSN
15273792
00225347
00225347